![]() |
ATTORNEYS AT LAW
777 EAST WISCONSIN AVENUE
MILWAUKEE, WI 53202-5306
414.271.2400 TEL
414.297.4900 FAX
WWW.FOLEY.COM
WRITER’S DIRECT LINE
CLIENT/MATTER NUMBER
103159-0101
|
|
VIA EDGAR SYSTEM
Mr. Daniel F. Duchovny
Special Counsel
Office of Mergers & Acquisitions
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-3628
|
|
1.
|
We note your disclosure that “[t]he Board has only one ‘Audit Committee Financial
Expert.’” With a view toward future revised disclosure, please tell us which of your nominees would qualify as such an expert. If none of your nominees are such experts but they are all elected while Mr. Erlich is not elected, the board
would retain no such experts; thus, revise your disclosure to clarify how the election of your nominees would affect the board. See Item 407(d) of Regulation S-K.
|
|
AUSTIN
BOSTON
CHICAGO
DALLAS
DENVER
|
DETROIT
HOUSTON
JACKSONVILLE
LOS ANGELES
MADISON
|
MEXICO CITY
MIAMI
MILWAUKEE
NEW YORK
ORLANDO
|
SACRAMENTO
SALT LAKE CITY
SAN DIEGO
SAN FRANCISCO
SILICON VALLEY
|
TALLAHASSEE
TAMPA
WASHINGTON, D.C.
BRUSSELS
TOKYO
|
|
2.
|
Your disclosure that “AVD’s Board has a pattern of providing selective and misleading
disclosures in its press releases and SEC filings” suggests that the current board and the company have not complied with the company’s disclosure obligations. You must avoid issuing statements that directly or indirectly impugn the
character, integrity or personal reputation or make charges of illegal, improper or immoral conduct without factual foundation. Please provide a factual foundation for your disclosure. In this regard, note that the factual foundation for
such assertion must be reasonable. Refer to Rule 14a-9.
|
|
•
|
The Company filed an incomplete performance chart in its 2021 Annual Report on Form 10-K, filed on March 14, 2022, resulting
in the chart missing important comparative data and misrepresenting the Company’s poor performance. See attached slides.
|
|
•
|
The Company stated in its Quarterly Report on Form 10-Q, filed on May 4, 2022, that “On March 8, 2022, pursuant to a Board of
Directors resolution, the Company announced its intention to repurchase an aggregate number of up to 1,000,000 shares of its common stock, par value $0.10 per share, in the open market over the succeeding one year at a price not to exceed $20 per share, subject to limitations and restrictions under applicable securities laws.” [Italics added] This statement is not
accurate because the Company did not disclose on March 8, 2022 that the repurchase program was subject to a cap of $20 per share. See the item below for further information on this point.
|
|
•
|
The Company reported the following in is Current Report on Form 8-K, filed on March 11, 2022: “In addition, the Company announced that its board of directors has approved a program for the repurchase of up to one million shares of common stock within the requirements of Exchange Act
Rule 10b-18 over the course of the next year. With respect to the repurchase program, Mr. Wintemute stated, “This authorization reflects the strong confidence that our board places in the company’s long-term success.” Nowhere in this
disclosure did the company report that the repurchase program was subject to “a price not to exceed $20 per share,” which is material piece of information. It is particularly material because it belies Mr. Wintemute’s statement that the Company has strong confidence in the
Company’s long-term success, as the cap of $20 per share is lower than the closing price of the Company’s stock since March 31, 2022.
|

|
•
|
The Company stated in its Current Report on Form
8-K, filed on May 2, 2022, that it had delivered “attractive returns” and “strong performance” relative to its agrochemical peers and the Russell 20000. This statement obfuscated the Company’s true performance by cherry-picking a random
day over a specific 7-year time-period against a comparative index the Company had never used before, the Russell 2000. Although AVD’s total shareholder return (TSR) was slightly favorable on that particular day, several days later on
May 6, AVD’s TSR underperformed the same index by -7% over the same 7-year period. And even over the specific time horizon selected by the Company, AVD still underperformed most every relevant peer and index.
|